This is a working overview of GHK-Cu, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-03-03 and is reviewed periodically as new material appears.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide binds copper through its histidine imidazole nitrogen, its terminal amino group, and a deprotonated amide nitrogen, creating a stable chelate ring. The resulting complex carries a distinctive blue to blue-violet color, which arises from copper d-d electronic transitions. In the solid state it is usually handled as a powder, while in solution the complex can dissociate and re-form depending on pH and competing ligands. The name copper tripeptide-1 is widely used in ingredient listings.
The tripeptide was first isolated from a human plasma filtrate in 1973 during studies of tissue repair factors. Later work detected the free peptide and its copper complex in saliva, urine, and wound fluid, suggesting a natural role in tissue remodeling. Plasma concentrations reported in early literature decline with age, a pattern often cited in discussions of skin aging. Whether these endogenous levels are directly functional or largely incidental remains an open question. The peptide sequence is conserved across mammalian species.
Solid GHK-Cu is generally stored as a dry powder under frozen conditions to limit degradation. The peptide bond can hydrolyze, and the copper center can be displaced by strong chelators such as EDTA. Aqueous solutions are less stable than the solid and may lose color or form precipitates over time. Temperature, pH, and oxygen exposure are the main variables that affect shelf life. Neutral to slightly acidic conditions tend to preserve the complex better than strongly alkaline media.
Routine handling calls for minimizing freeze-thaw cycles and preparing solutions shortly before use. Glass or inert plastic containers reduce adsorption and metal leaching. Working stocks are often kept at 2–8 °C for short periods, while long-term reference material stays at −20 °C or below. Light protection is prudent because prolonged exposure may accelerate oxidation of the peptide. Documentation of lot number, concentration, and preparation date supports reproducibility in laboratory work.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C14H24N6O4 | Free tripeptide, without copper |
| Molecular weight | About 340 g/mol | Peptide portion only |
| Appearance | Blue to violet powder | Color from copper coordination |
| Solubility | Soluble in water | pH influences dissolution |
| Common synonyms | Copper tripeptide-1, Cu-GHK | Seen on ingredient labels |
GHK-Cu is the copper-binding complex formed by the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The free peptide is usually written as GHK, and the complex is written as GHK-Cu or Cu-GHK. The sequence was identified in human plasma and later detected in saliva and urine. Its name comes from the single-letter codes of glycine, histidine and lysine. The complex is widely described as a naturally occurring carrier of copper in blood rather than as a free peptide with its own hormonal role.
Copper binds to the peptide through the histidine imidazole nitrogen and the terminal amino group, forming a stable square-planar complex. Binding constants reported for copper(II) with GHK are high, so the peptide competes effectively for copper in solution. The complex absorbs visible light, which gives solutions a blue to violet colour. Whether the metal-free peptide has a distinct biological function of its own is still an open question; some work treats it mainly as a copper delivery vehicle, while other work reports peptide-specific effects.
The sequence carries three residues in the order glycine, histidine, lysine, which places a small, flexible chain around a single metal centre. Compared with larger copper-binding proteins, the complex is compact and its coordination chemistry can be reproduced with synthetic peptide in a laboratory. Published structural work agrees on the nitrogen donor set but differs in the exact geometry assigned under some conditions, so the arrangement is best treated as well characterised in outline rather than fixed in every detail.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide was isolated from human plasma in the early 1970s by Loren Pickart, who observed that a plasma fraction from young donors stimulated growth in cultured liver cells. The copper-bound form is abbreviated GHK-Cu, while the metal-free peptide is written simply as GHK. In the research literature the complex also appears as copper tripeptide-1 and as glycyl-histidyl-lysine copper complex.
Isotope masses from: M. Wang; G. Audi; A. H. Wapstra; F. G. Kondev; M. MacCormick; X. Xu; et al. (2012). "The AME2012 atomic mass evaluation (II). Tables, graphs and references" (PDF). Chinese Physics C. 36 (12): 1603–2014. Bibcode:2012ChPhC..36....3M. doi:10.1088/1674-1137/36/12/003. hdl:11858/00-001M-0000-0010-23E8-5. S2CID 250839471. Archived from the original (PDF) on 2013-09-28. Retrieved 2013-07-03. Audi, Georges; Bersillon, Olivier; Blachot, Jean; Wapstra, Aaldert Hendrik (2003), "The NUBASE evaluation of nuclear and decay properties", Nuclear Physics A, 729: 3–128, Bibcode:2003NuPhA.729....3A, doi:10.1016/j.nuclphysa.2003.11.001 Half-life, spin, and isomer data selected from the following sources. Audi, Georges; Bersillon, Olivier; Blachot, Jean; Wapstra, Aaldert Hendrik (2003), "The NUBASE evaluation of nuclear and decay properties", Nuclear Physics A, 729: 3–128, Bibcode:2003NuPhA.729....3A, doi:10.1016/j.nuclphysa.2003.11.001 National Nuclear Data Center. "NuDat 3.0 database". Brookhaven National Laboratory. Holden, Norman E. (2004). "11. Table of the Isotopes". In Lide, David R. (ed.). CRC Handbook of Chemistry and Physics (85th ed.). Boca Raton, Florida: CRC Press. ISBN 978-0-8493-0485-9.
== Commercialization == When a new biopharmaceutical is developed, the company will typically apply for a patent, which is a grant to exclusive manufacturing rights. This is the primary means by which the drug developer can recover the investment cost for development of the biopharmaceutical. The patent laws in the United States and Europe differ somewhat on the requirements for a patent, with the European requirements perceived as more difficult to satisfy. The total number of patents granted for biopharmaceuticals has risen significantly since the 1970s. In 1978 the total patents granted was 30. This had climbed to 15,600 in 1995, and by 2001 there were 34,527 patent applications. Blood products and other human-derived biologics such as breast milk have highly regulated or very hard-to-access markets; therefore, customers generally face a supply shortage for these products. Institutions housing these biologics, designated as 'banks', often cannot distribute their product to customers effectively. Conversely, banks for reproductive cells are much more widespread and available due to the ease with which spermatozoa and egg cells can be used for fertility treatment.
==== Primate research ==== Evidence of gradual expansion of the frontal lobe during the evolutionary history of primates, as well as evidence of rapid expansion of nonfrontal neocortical regions that might have been linked to enhanced visual processing in primates, is presented by Kay et al. (2026). Cartmill & Brown (2026) review the history of the visual-predation theory, and argue that it represents the best available explanation for the origin of primates. A study on the morphology of molar teeth of extant and extinct members of Euarchonta, providing evidence of evolution of morphological changes associated with increased herbivory at the base of Euprimates, is published by Bradley-Cronkwright et al. (2026). Marigó et al. (2026) review new discoveries and main advances in the study of Paleogene primates from Spain from late 2013 to 2025. One of the oldest euprimate petrosal bones reported to date, likely belonging to Marcgodinotius indicus, is described from the Eocene strata from the Vastan Lignite Mine (India) by Silcox et al. (2026). Alfieri et al. (2026) reconstruct the locomotor behavior of Malagasy Quaternary lemurs on the basis of the study of their humeral and femoral trabecular architecture, reporting evidence of suspensory adaptations not only in sloth lemurs, but also in Megaladapis edwardsi. Robinson et al.
Sources: en.wikipedia.org
=== Women's rights === Bhutto Zardari is a strong advocate of "peaceful, progressive, prosperous, democratic Pakistan", what he calls his mother's vision. In an interview with the BBC, he said that his 2018 election campaign was to implement these principles. He is a strong supporter of women's empowerment and believes in empowering women and taking them on board in all matters is the sole guarantee of the country's progress. On the occasion of International Day of the Girl Child, the PPP chairman said that a future based on progress and prosperity could remain a dream without empowering girls and taking them on board in all matters. Bhutto Zardari acknowledged all those women who stepped forward in all sections of life and field while defeating many impediments at every level and social taboos. He specifically named Fatima Jinnah, Benazir Bhutto, Asma Jehangir, and Maryam Mukhtar. On 17 March 2019, Bhutto Zardari met with a delegation of women's rights activists led by Sheema Kirmani and assured his support for their cause. A statement released by Bhutto Zardari House later said that his party would not tolerate any offence against the struggle for gender equality and women's rights. The statement went further to read, "The PPP chairman extended his enduring support to the members of the Aurat March and its activists who are struggling for their genuine and legitimate rights as enshrined in the unanimous constitution of Pakistan." Bhutto Zardari has also advocated for the abolishment of child marriages in Pakistan.
June 19, 1987: Law concerning the duration and organization of working time. July 22, 1987: Law on the exercise of parental authority. July 18, 1988: Creation of the Secretary of State for Women's Rights, assigned to Michèle André. December 28, 1988: Order concerning the possession, distribution, dispensing, and administration of the drug Mifepristone 200 mg tablets. May 16, 1989: Decree removing the managerial and technical staff of the prison administration's external services from the list of positions for which separate recruitment could be planned for men and women. July 10, 1989: Framework law on education. July 10, 1989: Law on the prevention of child abuse and the protection of children. February 20, 1990: Order amending the order of November 3, 1988, concerning the prices of care and hospitalization related to voluntary termination of pregnancy. July 6, 1990: Law amending the Social Security Code and relating to family benefits and employment assistance for the care of young children. September 5, 1990: Marital rape is recognized for the first time by the Court of Cassation. December 21, 1990: The Council of State validates the conformity of the 1975 Veil Law with the European Convention on Human Rights. January 18, 1991: Law containing provisions relating to public health and social insurance. January 31, 1991: Decree concerning the responsibilities of the Secretary of State for Women's Rights and Daily Life, delegated by the Minister of Labour, Employment, and Vocational Training. May 1991: Édith Cresson becomes the first female Prime Minister of France.
===== Mexico ===== In March 2023, Brazilian presidential office said Mexican president Andres Manuel Lopez Obrador invited Lula to visit Mexico and discuss expanding economic cooperation between Mexico and Brazil including the removal of trade tariffs between their countries. In September 2024, Lula visited Mexico and separately met with President Andrés Manuel López Obrador and president-elect Claudia Sheinbaum. He later attended Sheinbaum's inauguration and joined the Brazilian-Mexican business forum which 400 business people attended.
Sources: en.wikipedia.org
It is a complex of the tripeptide glycyl-L-histidyl-L-lysine with a copper(II) ion. The peptide coordinates the metal through its histidine, amino terminus, and an amide nitrogen. It is often listed simply as copper tripeptide-1.
The peptide and its copper form have been detected in human plasma, saliva, and urine. Early reports describe levels that fall with age. The functional meaning of these pools is still debated.
Chromatographic separation gives peptide purity, often reported as a percentage. Copper content is checked by a separate elemental method. Moisture and counter-ions may be reported as well.
Dry powder is typically stored frozen at −20 °C or lower, protected from moisture and light. Short-term working amounts may be kept refrigerated. Avoiding repeated temperature changes helps preserve the material.